Form 4 for ARVN ARVINAS, INC.
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-18 · accession 0001655759-25-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-19 | 2025-03-18 | ARVN | Berkowitz Noah | Chief Medical Off | S - Sale | $8.59 | -8,658 | 110.0K | -7% | -$74.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-18 | S | D | 8,658 | $8.59 | 110,023 | D | — | — | (F1) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024. |